WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2014191397) TAMPER-RESISTANT DOSAGE FORM CONTAINING ONE OR MORE PARTICLES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2014/191397    International Application No.:    PCT/EP2014/060927
Publication Date: 04.12.2014 International Filing Date: 27.05.2014
Chapter 2 Demand Filed:    17.03.2015    
IPC:
A61K 9/14 (2006.01), A61K 9/20 (2006.01), A61K 9/16 (2006.01)
Applicants: GRÜNENTHAL GMBH [DE/DE]; Zieglerstraße 6 52078 Aachen (DE)
Inventors: BARNSCHEID, Lutz; (DE).
GEISSLER, Anja; (DE).
WENING, Klaus; (DE).
DENKER, Jana; (DE)
Agent: BÜLLE, Jan; Theodor-Heuss-Ring 23 50668 Köln (DE)
Priority Data:
13169658.5 29.05.2013 EP
14160958.6 20.03.2014 EP
Title (EN) TAMPER-RESISTANT DOSAGE FORM CONTAINING ONE OR MORE PARTICLES
(FR) FORME PHARMACEUTIQUE INVIOLABLE CONTENANT UNE OU PLUSIEURS PARTICULES
Abstract: front page image
(EN)The invention relates to a tamper-resistant pharmaceutical dosage form comprising one or more particles, wherein each of said one or more particles - comprises a pharmacologically active ingredient and a physiologically acceptable polymer; - has a breaking strength of at least 300 N; - has a weight of at least 2 mg; and - optionally, comprises a film-coating; wherein the total weight of the pharmaceutical dosage form is greater than the total weight of said one or more particles.
(FR)L'invention concerne une forme pharmaceutique inviolable comprenant une ou plusieurs particules, chacune desdites une ou plusieurs particules - comprenant un principe pharmacologiquement actif et un polymère physiologiquement acceptable ; - possédant une résistance à la rupture d'au moins 300 N ; - possédant un poids d'au moins 2 mg ; et - comprenant éventuellement un revêtement filmogène ; le poids total de la forme pharmaceutique étant supérieur au poids total desdites une ou plusieurs particules.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)